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Abstract
A recombinant transmissible gastroenteritis coronavirus (rTGEV) in which E gene was deleted (rTGEV-ΔE) has been engineered. This deletion
mutant only grows in cells expressing E protein (E+ cells) indicating that E was an essential gene for TGEV replication. Electron microscopy studies
of rTGEV-ΔE infected BHK-pAPN-E− cells showed that only immature intracellular virions were assembled. These virions were non-infectious and
not secreted to the extracellular medium in BHK-pAPN-E− cells. RNA and protein composition analysis by RNase-gold and immunoelectron
microscopy showed that rTGEV-ΔE virions contained RNA and also all the structural TGEV proteins, except the deleted E protein. Nevertheless, full
virion maturation was blocked. Studies of the rTGEV-ΔE subcellular localization by confocal and immunoelectron microscopy in infected E− cells
showed that in the absence of E protein virus trafficking was arrested in the intermediate compartment. Therefore, the absence of E protein in TGEV
resulted in two actions, a blockade of virus trafficking in the membranes of the secretory pathway, and prevention of full virus maturation.
© 2007 Elsevier Inc. All rights reserved.Keywords: Coronavirus; Nidovirus; E protein; TGEV; Virus maturationIntroduction
Since the identification of a novel coronavirus associated with
severe acute respiratory syndrome (SARS), and the discovery of
new human coronaviruses such as HCoV-NL63 and HCoV-NH,
associated with respiratory illnesses, the interest on corona-
viruses has clearly increased (Esper et al., 2005a, 2005b; Kuiken
et al., 2003; van der Hoek et al., 2004). The design of antiviral
drugs interfering with coronavirus replication (Hertzig et al.,
2004) and the development of replication-competent propaga-
tion-deficient virus vectors (Ortego et al., 2002) are potential
powerful tools to prevent and control coronavirus infections.
Transmissible gastroenteritis coronavirus (TGEV) is a mem-
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doi:10.1016/j.virol.2007.05.032(Enjuanes et al., 2000b). TGEV is an enveloped virus with a
single-stranded, positive-sense RNA genome of 28.5 kb. About
two-thirds of the genome encode the replicase gene, which
comprises open reading frames 1a and 1b, the last one being
expressed by ribosomal frameshifting (Brierley et al., 1989;
Penzes et al., 2001). The 3′ one-third of the genome includes
structural and nonstructural genes, in the order 5′-S-3a-3b-E-M-
N-7-3′ (Enjuanes et al., 2000a).
In the Coronaviridae family, the viral envelope contains at
least three structural proteins. The most abundant is the
membrane (M) protein, spanning the membrane three or four
times and interacting with the nucleocapsid (N) and spike (S)
proteins during assembly (Escors et al., 2001; Rottier, 1995).
The second most abundant is the S protein, a large type I-
transmembrane glycoprotein that forms peplomers and is
responsible for cell receptor binding and membrane fusion
(Lewicki and Gallagher, 2002; Sui et al., 2004; Suñé et al., 1990;
Suñé et al., 1991). The third is the small envelope (E) protein, a
transmembrane protein detected as aminor structural component
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infectious bronchitis virus (IBV) (Godet et al., 1992; Liu and
Inglis, 1991; Shen et al., 2003; Yu et al., 1994). Another essential
constituent of the virion is the N protein, an internal
phosphoprotein that interacts with the genomic RNA to form
the viral nucleocapsid (Escors et al., 2001; Kapke and Brian,
1986; Narayanan and Makino, 2001).
Coronavirus maturation takes place at the cis-Golgi network
also known as endoplasmic reticulum-Golgi intermediate
compartment (ERGIC) (Salanueva et al., 1999; Tooze et al.,
1984, 1987). The E protein plays an important role during
virus budding and transiently resides in a pre-Golgi compart-
ment before progressing to the Golgi apparatus (Corse and
Machamer, 2000; Maeda et al., 1999; Raamsman et al., 2000).
It has been proposed that the E protein induces virus envelope
curvature in pre-Golgi membranes during MHV and SARS-
CoV infections (Arbely et al., 2004; Kuo et al., 2002). Studies
on the assembly of coronavirus structural proteins by
heterologous mammalian expression systems have shown
that coexpression of E and M proteins from bovine coronavirus
(BCoV), MHV, TGEV, IBV, and SARS-CoV results in the
formation of virus like-particles (VLPs) that are morphologi-
cally identical to spikeless virions (Baudoux et al., 1998; Corse
and Machamer, 2000; Hsieh et al., 2005; Kuo et al., 2007;
Mortola and Roy, 2004; Vennema et al., 1996). In addition, it
has been described that both the MHV and IBV E proteins are
sufficient for the generation of VLPs (Corse and Machamer,
2000; Maeda et al., 1999). These observations suggested that
neither the N nor the S proteins are needed for viral budding.
In contrast, recent studies (Huang et al., 2004) described that
M and N proteins are necessary and sufficient for the
formation of SARS-CoV pseudoparticles. Therefore, the role
of E protein in coronavirus morphogenesis requires additional
studies.Fig. 1. Lack of rTGEV-ΔE propagation in E− cell lines. Analysis of virus propag
respectively, by plaque assay and immunofluorescence microscopy at 16 h p.i. usinThe construction of coronavirus full length cDNA clones
(Almazán et al., 2000; Casais et al., 2001; Thiel et al., 2001;
Yount et al., 2000, 2003) or strategies of targeted recombination
(Koetzner et al., 1992; Kuo et al., 2000; Masters, 1999) have
allowed the manipulation of viral genomes to study coronavirus
morphogenesis. Recently, a recombinant MHV virus with the
entire gene E deleted was constructed (Kuo and Masters, 2003).
This virus replicates with a low infectious titer, indicating that E
protein is critical, but not essential for MHV replication in vitro.
At variance, our laboratory has described an essential role for
the E protein during TGEV replication. rTGEV-ΔE virus was
rescued by complementation within E+ packaging cell lines
(Ortego et al., 2002).
In this article, we confirm that E protein is essential for
TGEV replication in different cell lines, and report the first
evidence that TGEV virions containing RNA are generated in
absence of E protein, although virus maturation was arrested in
the budding compartment, and immature virions were accumu-
lated between the rough endoplasmic reticulum and cis-Golgi.
These results provide evidence of an essential role of the E
protein during TGEV morphogenesis and in the intracellular
virus trafficking through the secretory pathway.
Results
Requirement of E protein for the generation of infective
rTGEV-ΔE virus
A replication-competent propagation-deficient rTGEV-ΔE
virus has been developed. This virus was rescued by com-
plementation within E+ packaging cell lines (Ortego et al.,
2002). To determine whether TGEV propagation deficiency
was dependent on the infected cell line, a collection of E− cell
lines permissive for TGEV replication (ST, CRFK, BHK-ation in rTGEV-wt and rTGEV-ΔE infected ST-E− cells at 24 and 96 h p.i.,
g a TGEV specific serum. Mock, non-infected cells.
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production was undetectable in infected BHK-pAPN, LLC-
PK1, ST, and CRFK E− cell lines either after 48 h post-
infection or during four consecutive cell passages. In contrast,
infection with rTGEV-ΔE of E+ cell lines produced infective
virus, with titers up to 107 pfu/ml in BHK-pAPN-E+ and 106
pfu/ml in LLC-PK1-E+. These data indicated that the lack of
infectious rTGEV-ΔE virus production was independent of the
cell line.
To confirm the propagation deficiency of rTGEV-ΔE, ST-
E− cells were infected with this virus and the propagation
analyzed by plaque assay and immunofluorescence micro-
scopy. Lysis plaques were observed in monolayers of ST-E−
cells infected with rTGEV-wt at 24 h post-infection, whereas
no plaques were generated by rTGEV-ΔE in these cells up to
96 h post-infection (Fig. 1). Immunofluorescence microscopy
of ST-E− cells infected at low m.o.i. (0.05) showed groups of
cells infected by rTGEV-wt at 16 h post-infection. In contrast,
single infected ST-E− cells were observed in monolayers
infected with rTGEV-ΔE virus (Fig. 1) at the same time post-Fig. 2. Characterization of intracellular and extracellular rTGEV-ΔE virus in BHK-
pAPN-E+ and E− cells by electron microscopy. Panels show sections from rTGEV-Δ
presence of TGEV proteins in supernatants was analyzed by SDS-PAGE using 5 to 2
the positions of TGEV structural proteins. (C) Electron micrographs of virions from
200-fold, and stained with 2% uranyl acetate are shown. Scale bar, 100 nm.infection and, later in the infection, the cells died and the
fluorescence disappear (data not shown), suggesting that ΔE
virions did not spread to neighboring uninfected cells and
confirming that rTGEV-ΔE was a replication-competent pro-
pagation-deficient virus.
Formation of TGEV virions in the absence of E protein
BHK-pAPN-E+ and E− cells infected with rTGEV-ΔE virus
were analyzed by electron microscopy to determine the
formation of TGEVvirions.Mature forms of the virions showing
a dense core (60-nm diameter), preferentially located inside
secretory vesicles, were abundant in infected BHK-pAPN-E+
cells at 24 h post-infection (Figs. 2A, E+), whereas large virus-
like particles, exhibiting an electron dense periphery and a
translucent central zone, were unexpectedly observed in infected
BHK-pAPN-E− cells at the same time post-infection (Figs. 2A,
E−). These large virus-like particles resembled the TGEV
immature virions previously reported (Risco et al., 1998) but
with a higher diameter (larger than 80-nm). Mature intracellularpAPN-E+ and E− cells. (A) Assembly characterization of rTGEV-ΔE in BHK-
E infected BHK-pAPN-E+ and E− cells at 24 h p.i. Scale bars, 300 nm. (B) The
0% gradient gels and silver staining. The arrows to the right of the panel indicate
supernatants of rTGEV-ΔE infected BHK-pAPN-E+ and E− cells concentrated
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E− cells.
To determine whether mature or immature virions were
secreted from rTGEV-ΔE infected BHK-pAPN-E− cells, the
presence of virions in the supernatants of infected BHK-pAPN-
E+ and E− cells was analyzed after virion purification by silver-
staining SDS-PAGE and negative-staining electron microscopy
(Fig. 2). No structural TGEV proteins were detected in theFig. 3. Characterization of rTGEV-ΔE virions by immunoelectron microscopy. rTG
shown. MAbs specific for the TGEV structural proteins S, M, N, and E (A) and a
processed by freeze-substitution in methanol. Panel B shows samples embedded in E
treated negative controls (−). Colloidal gold conjugates 10 nm in diameter were used
endoplasmic reticulum.supernatants of BHK-pAPN-E− cells infected with rTGEV-ΔE
at 48 h post-infection, whereas S, M, and N proteins were
detected in the supernatants of infected cells expressing E
protein (Fig. 2B). The absence of secreted virions in BHK-
pAPN-E− cells infected with rTGEV-ΔE was confirmed by
negative-staining electron microscopy on 200-fold concentrated
supernatants, whereas virions were observed in supernatants of
BHK-pAPN-E+ infected cells (Fig. 2C). These observationsEV-wt (WT) or rTGEV-ΔE (ΔE) infected BHK-pAPN-E− cells at 24 h p.i. are
complex of RNase and colloidal gold (B) were used. Panel A shows samples
ML-812. The specificity of RNase-gold labeling (+) was assessed with RNase-
for panels A and B. Scale bars, 100 nm. Mock, non-infected cells. RER, rugose
Fig. 4. Detection of TGEV structural proteins in rTGEV-ΔE infected BHK-
pAPN-E+ and E− cells by immunofluorescence. TGEV structural proteins were
detected by immunofluorescence using MAbs specific for S, M, N, and E
proteins in rTGEV-ΔE infected BHK-pAPN-E+ and E− cells at 16 h p.i.
300 J. Ortego et al. / Virology 368 (2007) 296–308demonstrated that rTGEV-ΔE infected BHK-pAPN-E− cells
did not secrete mature or immature virions.
Immunochemical characterization of rTGEV-ΔE virions
The composition of the large immature viral particles
assembled in BHK-pAPN-E− cells was determined by
immunogold detection in sections of freeze-substituted
samples. MAbs specific for S, M, and N proteins provided a
positive signal on the rTGEV-wt and rTGEV-ΔE virions
assembled on BHK-pAPN-E− cells, whereas only the rTGEV-
wt virions bound the MAb specific for E protein, as expected
(Fig. 3A).
To study whether rTGEV-ΔE virions incorporated RNA,
BHK-pAPN-E− cells infected with rTGEV-ΔE or rTGEV-wt
were analyzed by RNase-gold electron microscopic cytoche-
mistry. RNase-gold complex showed similar binding levels to
virions assembled on BHK-pAPN-E− cells infected with
rTGEV-ΔE or rTGEV-wt (Fig. 3B(+)) indicating that the
rTGEV-ΔE virions incorporated RNA. Binding of RNase-
gold to ribosomes of the rough endoplasmic reticulum (RER)
was also clearly observed (Fig. 3B(+)), whereas the RNase-
treated negative controls lacked any labeling either on ribo-
somes or on viral particles (Fig. 3B(−)), confirming binding
specificity.
Intracellular localization of TGEV structural proteins in
BHK-pAPN-E− cells infected with rTGEV-ΔE
The intracellular localization of TGEV structural proteins
was studied in BHK-pAPN-E− and E+ cells infected with the
rTGEV-ΔE by indirect immunofluorescence using MAbs
specific for TGEV S, M, N, and E proteins. The immunofluor-
escent signal associated with the TGEV structural proteinsM, N,
and S was similar in BHK-pAPN-E− and E+ cells (Fig. 4) with
some significative differences. Thus, proteins S and M were
accumulated in the perinuclear region in infected BHK-pAPN-
E− cells, whereas specific signals for these two proteins were
extended to the cytoplasm in infected BHK-pAPN-E+ cells.
Immunofluorescence specific for N protein was observed in the
cytoplasm of BHK-pAPN-E− and E+ cells but, in addition, a
punctuate immunofluorescence pattern that corresponded to the
accumulation of secretory vesicles in late infection stages was
also observed in BHK-pAPN-E+ cells (Salanueva et al., 1999).
The changes observed in the subcellular localization of the
TGEV structural proteins, in the absence of E protein, suggested
an arrest in TGEV intracellular transport, whereas in BHK-
pAPN-E+ cells rTGEV-ΔE virions progressed through the Golgi
to release from the cell by exocytosis.
Previous studies (Salanueva et al., 1999) suggested that
TGEV morphological transformation from large immature
particles into more condensed mature virus particles takes
place during its transport along the exocytic pathway. To
determine the effect of E gene deletion on TGEV infection of
BHK-pAPN-E− cells, the subcellular localization of virus
particles and endoplasmic reticulum (protein disulfide-isomer-
ase, PDI), intermediate compartment and cis-Golgi (KDELreceptor), and trans-Golgi (giantin) specific markers were
compared by immunofluorescence laser scanning confocal
microscopy in rTGEV-wt and rTGEV-ΔE infected BHK-
pAPN-E− and E+ cells at different times post-infection (0, 8,
14, and 24 h post-infection). The immunofluorescence pattern
observed with endoplasmic reticulum markers was similar in
BHK-pAPN-E+ and E− cells infected with rTGEV-wt or
rTGEV-ΔE, and in non-infected cells, at all the time points
analyzed, indicating that the overall distribution of this
organelle in the cell cytoplasm was not significantly affected
by any of these two viruses (Fig. 5). Only the time points 0 and
24 h are shown for simplicity.
KDEL receptor immunofluorescence specific signal in the
intermediate compartment and cis-Golgi was almost undetect-
able in rTGEV-wt infected BHK-pAPN-E− and E+ cells (Fig.
6). In contrast, the KDEL receptor specific signal in BHK-
pAPN-E− cells infected with rTGEV-ΔE showed a progressive
and strong accumulation at 24 h post-infection (Fig. 6).
Fig. 5. Detection of the endoplasmic reticulum marker PDI and rTGEV in BHK-pAPN-E+ and E− cells by immunofluorescence. TGEV infection and protein disulfide
isomerase (PDI) were monitored in BHK-pAPN-E+ and E− cells infected with rTGEV-wt and rTGEV-ΔE at 0 and 24 h p.i. by immunofluorescence microscopy using a
rabbit polyclonal antibody specific for PDI and a TGEV M protein specific MAb.
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KDEL-R was observed in rTGEV-ΔE infected E− cells,
consistent with the result obtained by confocal microscopy
(data not shown). Similar effect has been described (Salanueva
et al., 1999) when TGEV infection is blocked with monensin, a
drug that selectively affects the Golgi complex interrupting the
secretory pathway (data not shown). Furthermore, the infection
with rTGEV-ΔE in presence of E protein provided in trans
showed no accumulation of KDEL receptor (Fig. 6). These data
indicated that the accumulation of ERGIC vesicles could be a
consequence of a membrane trafficking blockade in the
secretory pathway leading to the inhibition of TGEV morpho-
genesis in the absence of E protein.
Staining for the Golgi complex in approximately 90% of
rTGEV-wt infected BHK-pAPN-E+ and E− cells showed
fragmentation and dispersion of Golgi membranes at 24 hpost-infection (Fig. 7), whereas this disruption of Golgi was
observed in only 20% of rTGEV-ΔE infected BHK-pAPN-E+
cells at 24 h post-infection probably due to the delay in the
infection progress. In fact, later in the infection, the disruption
Golgi was up to 100% in rTGEV-ΔE infected BHK-pAPN-E+
(data not shown). In contrast, disorganization of Golgi was not
observed in rTGEV-ΔE infected BHK-pAPN-E− cells at the
analyzed times, indicating that the virus maturation did not
progress from ERGIC to trans-Golgi in the absence of E
protein. Taken together, these data indicate an arrest in the virus
maturation in ERGIC, which is the TGEV budding compart-
ment (Salanueva et al., 1999).
To confirm that the virus particles were blocked in the
ERGIC in the absence of E protein, immunoelectron micro-
scopy was developed to analyze the markers of the membrane-
bound compartments containing virus particles. A different
Fig. 6. Detection of KDEL-R and rTGEV in BHK-pAPN-E+ and E− cells by immunofluorescence. TGEV infection and the ERGICmarker KDEL-R were monitored in
BHK-pAPN-E+ and E− cells infected with rTGEV-wt and rTGEV-ΔE at 0 and 24 h p.i. by immunofluorescence microscopy using a rabbit polyclonal antibody specific
for TGEV and a KDEL-R specific MAb.
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p58, was used due to the reduced signal observed for KDEL-R.
The antibody specific for ERGIC-53/p58 provided a positive
signal on the vesicles containing rTGEV-ΔE virions assembled
on ST-E− cells (Figs. 8A and B), whereas cytoplasm areas
without virus vesicles and nucleus lacked any labeling,
confirming the antibody binding specificity (Figs. 8A and C).
Discussion
It has been shown that E protein is essential for TGEV
morphogenesis. In TGEV-ΔE infected BHK-pAPN-E− cells
virions containing RNA were assembled, virus transportation
was arrested in the ERGIC and full virus maturation was
blocked and mature infectious virus was not secreted to the
extracellular medium.Previous studies have shown that, in the group 2 coronavirus
MHV and SARS-CoV (DeDiego et al., 2007; Kuo et al., 2002;
Kuo and Masters, 2003), E protein is not essential for virus
replication, although ΔE defective mutants have a reduced
growth in cell culture and in animal models. In contrast, for
group 1 coronavirus TGEV, we and others (Curtis et al., 2002;
Ortego et al., 2002) have shown that cells transfected with an E
gene-deleted TGEV infectious cDNA do not produce infectious
virus. Similarly, a gene E knockout mutant of the arterivirus
equine arteritis virus (EAV), is unable to produce infectious
progeny (Snijder et al., 1999). Kuo and Masters have suggested
that the apparent lethality of E gene knockouts in EAV and
TGEV may reflect a slow infection kinetics of these viruses that
would allow uninfected cells to overgrow infected cells and
obscure the detection of ΔE mutants of some nidovirus (Kuo
and Masters, 2003). Our results clearly showed, in this and in a
Fig. 7. Detection of giantin and rTGEV in BHK-pAPN-E+ and E− cells by immunofluorescence. TGEV infection and the Golgi apparatus marker giantin (gig) were
monitored in BHK-pAPN-E+ and E− cells infected with rTGEV-wt and rTGEV-ΔE at 0 and 24 h p.i. by immunofluorescence microscopy using a rabbit polyclonal
antibody TGEV specific and a giantin specific MAb.
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essential for TGEV replication and that no infectious virus was
produced at all. A simple explanation is that these viruses
belong to different CoV groups and have different assembly
requirements. The generation of infectious rTGEV-ΔE virus
was dependent on E protein expression and independent of the
infected cell line. Thus, rTGEV-ΔE infected cells did not
secrete virus to the extracellular medium, and the virus did not
spread to neighboring uninfected cells, and therefore did not
generate plaques in infected ST-E− cells up to 96 h post-
infection, confirming that rTGEV-ΔE is a propagation-deficient
virus in the absence of E protein provided in trans. Furthermore,
no virus amplification was observed using supernatants or cell
extracts from BHK-pAPN-E− cells infected with rTGEV-ΔE
virus when used to infect fresh BHK-pAPN-E+ cells, although
these cells could have amplified minute amounts of rTGEV-ΔEvirus. These data confirmed that E protein was essential for
TGEV virus replication. Therefore, a different behavior is shown
by coronavirus from groups 1 and 2 in the requirement for E
protein during virus assembly.
The requirement of E and M proteins for the formation of
virus-like particles has been previously described (Vennema
et al., 1996). Co-infection with recombinant baculoviruses
showed that the membrane and envelope proteins are
sufficient for the efficient formation of coronavirus VLPs
(Mortola and Roy, 2004). In contrast, Huang and coworkers
reported that two viral genes, encoding the SARS-CoVM and N
proteins, are necessary and sufficient for formation of VLPs by
cotransfection of expression plasmids (Huang et al., 2004). This
discrepancy could be explained by the different cell types used in
these studies (insect Sƒ9 and human 293Tcells, respectively). In
our study, electron microscopy analysis of BHK-pAPN-E− cells
Fig. 8. Immunoelectron microscopy of ERGIC in rTGEV-ΔE infected ST-E− cells. Panel A and B show vesicles filled with viruses that react with the anti-ERGIC-53/
p58 antibody, specific marker for the intermediate compartment. Panel C shows a detail of the cytoplasm and nucleus where ERGIC-53/p58 specific signal was not
observed. ERGIC-53/p58 specific signal is indicated with arrows. v, viruses; N, nucleus. Scale bars, 100 nm.
304 J. Ortego et al. / Virology 368 (2007) 296–308infected with rTGEV-ΔE demonstrated that only immature
TGEV virions were assembled in the absence of E protein. These
virions contained RNA, and also all the structural TGEV
proteins (S,M, and N) except the deleted E protein. These results
indicate that the E protein is essential for the formation of mature
TGEV virions. In the absence of E protein, the assembled virions
displayed a morphology different from the full-length virus,
were non-infectious, accumulated in the cytoplasm of the
infected cells, and were not released to the extracellular medium
or transported to neighboring cells.
TGEV replication depends on the exocytic pathway to
complete its morphogenesis (Salanueva et al., 1999). Virions
were assembled as large particles with annular morphology at
perinuclear compartment of the cells, and changed their
morphology into small dense virions during the transport
along the exocytic route (Risco et al., 1998; Tooze et al., 1987).
In cells infected with rTGEV-ΔE, an accumulation of the KDEL
receptor and the lack of fragmentation and dispersion of Golgi
membranes were observed in absence of E protein. These
effects and rTGEV-ΔE virus assembly into mature particles
were recovered by providing E protein in trans. In addition,
immunoelectron microscopy studies with an intermediate
compartment specific marker confirmed that, in the absence
of the E protein, the maturation of the virus is arrested in theERGIC. A similar effect has been described when TGEV
infection is blocked with monensin, a drug that selectively
affects the Golgi complex interrupting the secretory pathway.
Monensin blocks the viral transport from ERGIC, leading to the
accumulation of numerous large viral particles in dilated pre-
Golgi ERGIC elements of vacuolar morphology (Salanueva et
al., 1999). The comparable deficiencies observed in viral
morphogenesis in the absence of E protein and as a result of
treatment with monensin suggest an aberrant assembly process
due to the absence of E protein. In principle, E protein could act
directly on the ERGIC and Golgi compartments, on the virus
itself, or in both. It has been postulated that E protein prepares
the membrane or other viral proteins occupying strategic
positions within the budding pathways (Salanueva et al.,
1999), as proposed for small acylated glycoproteins of alpha-
viruses and orthomyxoviruses that also display ion channel
activity (Gaedigk-Nitschko et al., 1990; Ivanova et al., 1995;
Liao et al., 2006; Wilson et al., 2004; Zebedee and Lamb, 1988).
The absence of E protein would inhibit the progression through
the ERGIC-Golgi compartments, resulting in the accumulation
of virions in the ERGIC and of the ERGIC itself.
E proteins from MHV and SARS-CoV have viroporin
activity (Liao et al., 2004; Madan et al., 2005). Viroporins act at
late stages of the viral cycle promoting the exit of new virus
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mechanism by which viroporins alter the permeability of the
plasma membrane is unknown, and it is possible that this
activity is displayed both at the plasma membrane and on
cellular organelles (Aldabe et al., 1997; Van kuppeveld et al.,
1997). Coronavirus E protein localizes in membranes of
ERGIC, where it could modify their permeability, leading to
the disruption of ion gradients at intracellular organelles (Madan
et al., 2005), facilitating the transport of the virions along the
exocytic pathway and their maturation. The absence of this
viroporin activity mediated by the E protein possibly leads to
the arrest of the transport of virions through the secretory
pathway, the accumulation of non-mature virions in ERGIG,
and the absence of release of new infectious virus from the cell.
The construction of E protein mutants affecting E protein ion
channel activity could assess whether this postulate is correct.
E proteins from the different coronavirus groups show
different channel selectivity. The E protein from the group 1
coronavirus HCoV-229E is K+ selective, whereas from the
group 2 MHVand SARS-CoV, and group 3 coronavirus IBV, E
protein is Na+ selective (Wilson et al., 2006, 2004). The diverse
channel selectivity among the coronavirus groups could be
translated in differences in the effect of E protein in the
secretory pathway and may explain the discrepancies among the
gene E-defective mutants from the three coronavirus groups,
and why E protein is essential for replication of group 1 viruses
and non-essential for replication of group 2 viruses. Additional
analysis of the gene E-defective mutants during assembly is
required to shed light on the functions of the E protein in
coronavirus morphogenesis in the three virus groups of the
Coronaviridae family.
In conclusion, the arrest of TGEV maturation and the
accumulation of virions in the secretory pathway due to the
absence of the E protein confirm that this protein is essential for
TGEV transportation andmorphogenesis. The ability to generate
TGEV-ΔE mutants that are replication-competent but propaga-
tion-deficient by complementation in packaging cell lines,
supports the potential use of these mutants as vaccine vectors.
Materials and methods
Virus and cells
Recombinant rTGEV-MluI–FseI (rTGEV-wt) and rTGEV-
Δ3abΔE (rTGEV-ΔE) (Ortego et al., 2002, 2003) were grown
as described (Jiménez et al., 1986). Baby hamster cells (BHK-
21) stably transformed with the gene coding for the porcine
aminopeptidase N (BHK-pAPN) (Delmas et al., 1992) were
grown in Dulbecco's modified Eagle's medium (DMEM)
supplemented with 2% fetal calf serum (FCS) containing
Geneticin G418 (1.5 mg/ml) as a selector agent. Porcine kidney
cells, LLC-PK1 (European Collection of Cell cultures no.
86121112), were grown in medium 199 supplemented with
2 mM glutamine and 10% FCS. Cat kidney cells, CRFK (ATCC
CCL 94), were grown in DMEM supplemented with 2% FCS.
BHK-pAPN-E+ and LLC-PK1-E+ cells were grown as
described previously (Ortego et al., 2002). Standard virustitrations were performed in porcine swine testis (ST) cells.
Titrations of virus with the E gene deleted were performed in
LLC-PK1 cells expressing the E protein.
Antibodies
The murine MAbs 1D.G3, 3B.B3, and 3B.D10, specific for
TGEV S, M, and N proteins, respectively, have been previously
described (Gebauer et al., 1991; Risco et al., 1995; Sánchez et
al., 1990). The murine MAb Q3, specific for TGEV E protein,
was a kind gift of H. Laude (INRA, Jouy-en Josas, France). The
rabbit serum specific for PDI and the murine MAb specific for
giantin was generously provided by A. Nieto (Centro Nacional
de Biotecnología, CSIC, Madrid, Spain) and M. Renz (Institute
of Immunology and Molecular Genetics, Karlsruhe, Germany),
respectively. The murine MAb specific for KDEL receptor and
the rabbit polyclonal antibody specific for ERGIC-53/p58 were
purchased from Stressgen Biotechnologies Corp. (Victoria, BC,
Canada) and Sigma-Aldrich (St. Louis. MO, USA), respectively.
TGEV virion purification
TGEV virions were sedimented through a 20% sucrose
cushion in TEN (Tris–HCl 10 mM [pH 7.4], EDTA 1 mM,
NaCl 1M) 0.2% Tween 20 by centrifugation in an SW28
Beckman rotor at 25,000 rpm for 2 h at 4 °C. Sucrose was
removed and the pellet was washed with TEN. Pellet was
recovered by suspending it in TEN-0.2% Tween 20 and
sedimented by centrifugation in a SW 41 Beckman rotor for
1 h at 25,000 rpm. Virions were recovered by suspending the
pellet in TNE (Tris–HCl 10 mM [pH 7.4], EDTA 1 mM, NaCl
100 mM) and analyzed by sodium dodecyl sulfate-polyacryla-
mide gel electrophoresis (SDS-PAGE) and silver staining or
negative staining and electron microscopy.
Electron microscopy
Processing of infected cells for embedding in EML-812 for
ultrastructural studies
Monolayers of BHK-pAPN cells expressing TGEV E
protein and control cells were infected with rTGEV-wt or
rTGEV-ΔE virus. The cells were fixed in situ at 12, 16, and 24 h
post-infection with a mixture of 2% glutaraldehyde and 1%
tannic acid in 0.4 M HEPES buffer (pH 7.2) for 2 h at room
temperature. The fixed monolayers were removed from the
dishes in the fixative and transferred to Eppendorf tubes. After
centrifugation in a microcentrifuge, the cell pellets were washed
with HEPES buffer and processed for embedding in EML-812
(Taab Laboratories, Berkshire, United Kingdom) as described
(Risco et al., 1998). The cells were post-fixed with a mixture of
1% osmium tetroxide and 0.8% potassium ferricyanide in
distilled water for 1 h at 4 °C. After four washes with HEPES
buffer, samples were incubated with 2% uranyl acetate, washed
again, and dehydrated in increasing concentrations of acetone
(50, 70, 90, and 100%) for 15 min each at 4 °C. Infiltration in
the resin EML-812 was done at room temperature for 1 day.
Polymerization of infiltrated samples was done at 60 °C for
306 J. Ortego et al. / Virology 368 (2007) 296–3082 days. Ultrathin (50- to 60-nm-thick) sections of the samples
were stained with saturated uranyl acetate and lead citrate by
standard procedures.
Quick freezing and freeze-substitution of cells
Cultures of cells were subjected to a mild fixation with a
solution of 4% paraformaldehyde containing 0.1% glutaralde-
hyde in PBS at 4 °C for 30 min. Small pellets of chemically
fixed cells were cryoprotected with glycerol, applied to small
pieces of filter paper, blotted, and quick frozen in liquid
ethane. Vitrified specimens were transferred to a Reichert-Jung
AFS freeze-substitution unit (Leica, Vienna, Austria) and
maintained for 48 h at −90 °C in a mixture of methanol and
0.5% (w/v) uranyl acetate. After freeze-substitution, samples
were infiltrated in Lowicryl K4M (EML Laboratories) at
−30 °C and polymerized with UV light. Ultrathin sections of
the samples were either stained or processed for immunogold
labeling.
Immunoelectron microscopy
Immunogold detection of TGEV proteins on ultrathin-
sections of infected BHK-pAPN cells was performed at room
temperature with MAbs specific for M, N, S, E, and ERGIC-53
proteins by established procedures (Risco et al., 1995). Sections
collected on Formvar coated gold electron microscopy grids
were incubated for 30 min with Tris buffer-gelatin and then
floated on drops of diluted primary antibodies for 75 min. After
jet washing with PBS, samples were incubated for 45 min with
secondary antibodies conjugated with 10-nm-diameter gold
particles and washed again with PBS and distilled water.
Samples were then allowed to dry on filter paper before being
stained with saturated uranyl acetate for 25 min, followed by
1 min with lead citrate. All samples were analyzed with a JEOL
1200 EX II electron microscope.
For ultrastructural detection of RNA, a complex of RNase and
10-nm-diameter colloidal gold (EY Laboratories, San Diego,
CA) was used as described previously (Risco et al., 1998).
Ultrathin sections from Epon-included samples were collected
on gold electron microscopy (EM) grids covered with collodion
and incubated for 40 min at room temperature with the gold
conjugated RNase diluted 1:20 in PBS. After being washed with
PBS and distilledwater, sampleswere stainedwith uranyl acetate
and lead citrate. To unmask viral RNA molecules, sections were
subjected to a treatment before incubation with RNase-gold
consisting on 15 min incubation at 37 °C with proteinase K
(10 μg/ml in Tris-EDTA), washingwith TE, 10min fixation with
4% paraformaldehyde in PBS, washing again with PBS, and
incubation for 10 min with 0.2 M NH4Cl. As a cytochemical
control, some sections were pre-incubated for 30 min at 37 °C
with a solution of non-conjugatedRNase (20μg/ml) before being
treated with the RNase-gold conjugated.
Negative staining of rTGEV-ΔE virions
Virus from supernatants of BHK-pAPN-E+ and E− cells
infected with rTGEV-ΔE virus, concentrated 200-fold, were
analyzed by negative staining as described (Bremer et al.,
1998). Briefly, samples were adsorbed to UV light-activatedcopper grids for 2 min at room temperature. Grids were washed
two times in H2O (Escors et al., 2001) and stained with 2%
uranyl acetate for 1 min. Samples were visualized in a JEOL
1200 EXII transmission electron microscope.
Immunofluorescence
Cells were plated on glass coverslips. Infections were
performed at an m.o.i. =1 pfu/cell at 37 °C in DMEM
containing 2% FCS. The inoculum was removed at 90 min
and the cells were maintained in DMEM 2% FCS. At the times
indicated, cells were washed with PBS and fixed by addition of
4% paraformaldehyde for 30 min at room temperature. For
dual-labeling experiments in which, one primary antibody was
derived from mouse and the other one from rabbit, both
antibodies were combined in a PBS-FCS 20% diluent contain-
ing 0.2% Saponin (Superfos-Biosector, Vedback, Denmark).
Antibodies were allowed to adsorb for 90 min at room
temperature, and washed three times with PBS-FCS 2%. Cells
were then incubated for 30 min at room temperature with a
mixture of anti-rabbit and anti-mouse secondary antibodies
conjugated to Alexa 488 or Alexa 594. The coverslips were
washed five times with PBS-FCS 2%, mounted on glass slides,
and analyzed with a Laser Scanning Confocal System Radiance
2100 (Bio-Rad) on a Zeiss Axiovert 200 microscope. Argon ion
and He–Ne lasers at 488 and 543 nm were employed as
excitation sources. Image acquisition was performed using
LaserSharp2000 v.5 software.
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